Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban)
- 1 October 2001
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 88 (8) , 884-886
- https://doi.org/10.1016/s0002-9149(01)01897-5
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: Ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventionsAmerican Heart Journal, 2000
- Early Potent Antithrombotic Effect With Combined Aspirin and a Loading Dose of Clopidogrel on Experimental Arterial Thrombogenesis in HumansCirculation, 2000
- Ticlopidine and ClopidogrelCirculation, 1999
- The Antiplatelet Effects of Ticlopidine and ClopidogrelAnnals of Internal Medicine, 1998
- Myonecrosis After Revascularization ProceduresJournal of the American College of Cardiology, 1998
- The Myth of the Myocardial ‘Infarctlet’ During Percutaneous Coronary Revascularization ProceduresCirculation, 1996